Ibuprofen recall
There is currently a major nationwide recall of children's ibuprofen that was initiated in March 2026.
The U.S. Food and Drug Administration (FDA) announced the recall of nearly 90,000 bottles after receiving complaints that the medication contained a "gel-like mass and black particles."
Here are the specific details of the recalled medication:
Recalled Product Information
Product: Children's Ibuprofen Oral Suspension, USP (100 mg per 5 mL), Berry Flavor
Size: 4 fluid ounce (120 mL) bottles
Manufacturer: Manufactured in India by Strides Pharma Inc. for Taro Pharmaceuticals U.S.A., Inc.
Lot Numbers: 7261973A and 7261974A
Expiration Date: January 31, 2027
Safety and Risk Level
FDA Classification: This has been classified as a Class II recall. This means that exposure to the product might cause temporary or medically reversible adverse health consequences, but the probability of serious or permanent harm is considered low.
Reported Illnesses: As of now, the FDA has not received any reports of serious injuries or adverse health effects connected to the recalled medication.
What to Do
If you have this specific medication in your cabinet:
Stop use immediately: Do not administer any more of the medication.
Check the label: Verify the lot number and expiration date to see if your bottle is part of the recall.
Dispose or return: Follow the recall instructions for returning the product or disposing of it safely.
Consult a professional: Reach out to a healthcare provider if a child has already consumed the medication and you have concerns.
You Might Also Enjoy...
Microplastics in our food
The Vicious Cycle of Childhood Obesity
Measles Outbreak Maricopa County
2025-2030 dietary guidelines updates for toddlers
